A man named Peter Marks sits as the Director of the FDA CBER and seemingly had a hand in withholding novavax.
That said it was approved today - I expect pharmacy to have stock within 7-21 days depending on supply chain logistics which I have no clue how that works.
https://www.fda.gov/news-events/press-a ... irculating
Novavax targets the JN1 variant lineage. all KP lineages come from JN1.11.1 variants. So far data shows that Novavax offers longer lasting and wider range of protection over mRNA vaccines.